Madathan Kandi Sibin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Madathan Kandi Sibin has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Chetan Gk
Department of Human Genetics, National Institute of Mental Health and Neuro Sciences, Bangalore, 560029, India.
8 shared publications Pratibha Misra
5 shared publications- Pratibha Misra
Professor & Head, Department of Biochemistry, Armed Forces Medical College, Pune, India
5 shared publications Dhananjaya I. Bhat
Department of Neurosurgery, National Institute of Mental Health and Neuro Sciences, Bangalore, India
4 shared publications- Yaongamphi Vashum
Department of Biochemistry, Armed Forces Medical College, Pune 411040, India
4 shared publications - Arati Suvatha
Department of Human Genetics, National Institute of Mental Health and Neuro Sciences, Bangalore/Karnataka, Karnataka, 560029, India
3 shared publications
Latest Publications
- Open Access
- 8 July 2026
- Published byĀ ElsevierĀ inĀ Journal of Ayurveda and Integrative Medicine
- Vol.Ā 17 Ā (4) , 101376
Biochemical rationale for dietary management of COVID-19 patients: Indian traditional millets as a promising integrative nutritional strategy
- 8 July 2026
- Published byĀ ElsevierĀ inĀ Journal of Ayurveda and Integrative Medicine
- Vol.Ā 17 Ā (4) , 101376
Open AccessBiochemical rationale for dietary management of COVID-19 patients: Indian traditional millets as a promising integrative nutritional strategy
- Open Access
- 24 September 2025
- Published byĀ MDPI AGĀ inĀ Epigenomes
- Vol.Ā 9 Ā (4) , 37
Sustained Higher Levels of Plasma hsa-miR-17-5p Expression During Gestational Diabetes Mellitus and Postpartum
Background: The role of circulatory miRNAs in gestational diabetes mellitus (GDM) was explored extensively in previous studies. However, there was limited literature on longitudinal studies exploring the changes in miRNA expression during pregnancy and postpartum to understand the changes in their expression levels in GDM patients. Methods: Blood samples from thirty GDM subjects and twenty normoglycemic pregnant women (NGT) were collected between 24 and 28 weeks of their pregnancy, and follow-up samples from the same subjects were collected till 12 weeks postpartum (FGDM and FNGT, respectively). Three candidate miRNAs, hsa-miR-16-5p, hsa-miR-17-5p, and hsa-miR-20a-5p, were quantified from their plasma samples using RT-qPCR. Comparative analysis of these miRNA expression levels was made between different groups. Results: hsa-miR-16-5p, hsa-miR-17-5p, and hsa-miR-20a-5p expression were significantly higher in GDM patients when compared to NGT subjects. Interestingly, hsa-miR-17-5p has shown consistent upregulation in FGDM even after these patients turned normoglycemic. Additionally, hsa-miR-16-5p was found to be higher in FGDM patients compared to FNGT subjects. Conclusions: The present study corroborated the finding of differential expression of hsa-miR-16-5p, hsa-miR-17-5p, and hsa-miR-20a-5p in GDM. It also marked the importance of monitoring the levels of hsa-miR-17-5p and hsa-miR-16-5p during pregnancy and postpartum in GDM patients.
- 24 September 2025
- Published byĀ MDPI AGĀ inĀ Epigenomes
- Vol.Ā 9 Ā (4) , 37
Open AccessSustained Higher Levels of Plasma hsa-miR-17-5p Expression During Gestational Diabetes Mellitus and Postpartum
Background: The role of circulatory miRNAs in gestational diabetes mellitus (GDM) was explored extensively in previous studies. However, there was limited literature on longitudinal studies exploring the changes in miRNA expression during pregnancy and postpartum to understand the changes in their expression levels in GDM patients. Methods: Blood samples from thirty GDM subjects and twenty normoglycemic pregnant women (NGT) were collected between 24 and 28 weeks of their pregnancy, and follow-up samples from the same subjects were collected till 12 weeks postpartum (FGDM and FNGT, respectively). Three candidate miRNAs, hsa-miR-16-5p, hsa-miR-17-5p, and hsa-miR-20a-5p, were quantified from their plasma samples using RT-qPCR. Comparative analysis of these miRNA expression levels was made between different groups. Results: hsa-miR-16-5p, hsa-miR-17-5p, and hsa-miR-20a-5p expression were significantly higher in GDM patients when compared to NGT subjects. Interestingly, hsa-miR-17-5p has shown consistent upregulation in FGDM even after these patients turned normoglycemic. Additionally, hsa-miR-16-5p was found to be higher in FGDM patients compared to FNGT subjects. Conclusions: The present study corroborated the finding of differential expression of hsa-miR-16-5p, hsa-miR-17-5p, and hsa-miR-20a-5p in GDM. It also marked the importance of monitoring the levels of hsa-miR-17-5p and hsa-miR-16-5p during pregnancy and postpartum in GDM patients.
- 7 February 2024
- Published byĀ ElsevierĀ inĀ Medical Journal Armed Forces India
- Vol.Ā 80 Ā (2) , 184-191
To study childhood trauma in patients with bipolar affective disorder and its association with leucocyte telomere length
- 7 February 2024
- Published byĀ ElsevierĀ inĀ Medical Journal Armed Forces India
- Vol.Ā 80 Ā (2) , 184-191
To study childhood trauma in patients with bipolar affective disorder and its association with leucocyte telomere length
- 12 May 2023
- Published byĀ Springer NatureĀ inĀ International Journal of Diabetes in Developing Countries
- Vol.Ā 43 Ā (6) , 1043-1051
Circulatory levels of multiple microRNA associated with prediabetes
- 12 May 2023
- Published byĀ Springer NatureĀ inĀ International Journal of Diabetes in Developing Countries
- Vol.Ā 43 Ā (6) , 1043-1051
Circulatory levels of multiple microRNA associated with prediabetes
- Open Access
- 27 April 2023
- Published byĀ Open Exploration PublishingĀ inĀ Exploration of Medicine
- Vol.Ā 4 Ā (2) , 286-298
Serum levels of ceruloplasmin and magnesium in polycystic ovarian syndrome: a cross sectional study
Aim: Polycystic ovarian syndrome (PCOS) is the most common endocrine condition, affecting 5ā7% of reproductive-age women worldwide. It is associated with low-grade chronic inflammation, insulin resistance, and metabolic syndrome. Studies have shown ceruloplasmin (Cp) as an independent risk factor for metabolic syndrome and magnesium (Mg), which is required for proper glucose utilization. This study aimed to compare the serum Mg and Cp in PCOS and healthy women and correlate their levels with changes in biochemical, hormonal, and gynaecological aspects of PCOS. Methods: The study comprised 98 women diagnosed with PCOS using the Rotterdam criteria and 75 age-matched healthy control subjects. The level of serum Cp and Mg were determined using Somani Ambade colorimetric method and methylthymol blue method respectively. Results: Serum Cp was higher and Mg levels were lower significantly in PCOS patients in comparison with controls. Mg was inversely correlated with fasting blood glucose and directly correlated with follicle-stimulating hormone (FSH). Cp was inversely correlated with prolactin and thyroid-stimulating hormone. Multiple regression analysis revealed that Cp correlates with both the level of luteinizing hormone (LH) and LH/FSH ratio, whereas serum Mg did not have a significant correlation with any of the clinical variables. Logistic regression analysis revealed elevated Cp, antral follicle count (AFC), body mass index (BMI), weight, and irregular menses increase the risk of developing PCOS, whereas Mg was not a risk factor. However, high LH and LH/FSH ratios were risk factors for hypomagnesemia. In conclusion, serum Cp levels in PCOS may be evaluated as an additional risk factor in association with AFC, BMI, weight, and irregular menses. Conclusions: Mg deficiency and high Cp play an important etiological role in PCOS pathogenesis. Thus, research evaluating dietary interventions and supplementation is warranted.
- 27 April 2023
- Published byĀ Open Exploration PublishingĀ inĀ Exploration of Medicine
- Vol.Ā 4 Ā (2) , 286-298
Open AccessSerum levels of ceruloplasmin and magnesium in polycystic ovarian syndrome: a cross sectional study
Aim: Polycystic ovarian syndrome (PCOS) is the most common endocrine condition, affecting 5ā7% of reproductive-age women worldwide. It is associated with low-grade chronic inflammation, insulin resistance, and metabolic syndrome. Studies have shown ceruloplasmin (Cp) as an independent risk factor for metabolic syndrome and magnesium (Mg), which is required for proper glucose utilization. This study aimed to compare the serum Mg and Cp in PCOS and healthy women and correlate their levels with changes in biochemical, hormonal, and gynaecological aspects of PCOS. Methods: The study comprised 98 women diagnosed with PCOS using the Rotterdam criteria and 75 age-matched healthy control subjects. The level of serum Cp and Mg were determined using Somani Ambade colorimetric method and methylthymol blue method respectively. Results: Serum Cp was higher and Mg levels were lower significantly in PCOS patients in comparison with controls. Mg was inversely correlated with fasting blood glucose and directly correlated with follicle-stimulating hormone (FSH). Cp was inversely correlated with prolactin and thyroid-stimulating hormone. Multiple regression analysis revealed that Cp correlates with both the level of luteinizing hormone (LH) and LH/FSH ratio, whereas serum Mg did not have a significant correlation with any of the clinical variables. Logistic regression analysis revealed elevated Cp, antral follicle count (AFC), body mass index (BMI), weight, and irregular menses increase the risk of developing PCOS, whereas Mg was not a risk factor. However, high LH and LH/FSH ratios were risk factors for hypomagnesemia. In conclusion, serum Cp levels in PCOS may be evaluated as an additional risk factor in association with AFC, BMI, weight, and irregular menses. Conclusions: Mg deficiency and high Cp play an important etiological role in PCOS pathogenesis. Thus, research evaluating dietary interventions and supplementation is warranted.
- 1 July 2022
- Published byĀ ElsevierĀ inĀ Medical Journal Armed Forces India
- Vol.Ā 78 Ā (3) , 322-326
A pilot study on DNA hypermethylation status in promoter region of P16 gene in patients with sporadic breast cancer
- 1 July 2022
- Published byĀ ElsevierĀ inĀ Medical Journal Armed Forces India
- Vol.Ā 78 Ā (3) , 322-326
A pilot study on DNA hypermethylation status in promoter region of P16 gene in patients with sporadic breast cancer